Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg

JR Zalcberg; Jaap Verweij; PG Casali; A le Cesne; P Reichardt; JY Blay; M Schlemmer; M Glabbeke; M Brown; IR Judson

doi:10.1016/j.ejca.2005.04.034

Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg

JR Zalcberg, Jaap Verweij, PG Casali, A le Cesne, P Reichardt, JY Blay, M Schlemmer, M Glabbeke, M Brown, IR Judson

Research output: Contribution to journal › Article › Academic › peer-review

343 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1751-1757
Number of pages	7
Journal	European Journal of Cancer
Volume	41
Issue number	12
DOIs	https://doi.org/10.1016/j.ejca.2005.04.034
Publication status	Published - 2005
Externally published	Yes

Research programs

EMC MM-03-86-08

Access to Document

10.1016/j.ejca.2005.04.034

http://hdl.handle.net/1765/60833

Cite this

Zalcberg, JR., Verweij, J., Casali, PG., le Cesne, A., Reichardt, P., Blay, JY., Schlemmer, M., Glabbeke, M., Brown, M., & Judson, IR. (2005). Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg. European Journal of Cancer, 41(12), 1751-1757. https://doi.org/10.1016/j.ejca.2005.04.034

@article{09aacac8af0d4f0f8d85e4c09aa62dbe,

title = "Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg",

author = "JR Zalcberg and Jaap Verweij and PG Casali and {le Cesne}, A and P Reichardt and JY Blay and M Schlemmer and M Glabbeke and M Brown and IR Judson",

year = "2005",

doi = "10.1016/j.ejca.2005.04.034",

language = "Undefined/Unknown",

volume = "41",

pages = "1751--1757",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

number = "12",

}

Zalcberg, JR, Verweij, J, Casali, PG, le Cesne, A, Reichardt, P, Blay, JY, Schlemmer, M, Glabbeke, M, Brown, M & Judson, IR 2005, 'Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg', European Journal of Cancer, vol. 41, no. 12, pp. 1751-1757. https://doi.org/10.1016/j.ejca.2005.04.034

TY - JOUR

T1 - Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg

AU - Zalcberg, JR

AU - Verweij, Jaap

AU - Casali, PG

AU - le Cesne, A

AU - Reichardt, P

AU - Blay, JY

AU - Schlemmer, M

AU - Glabbeke, M

AU - Brown, M

AU - Judson, IR

PY - 2005

Y1 - 2005

U2 - 10.1016/j.ejca.2005.04.034

DO - 10.1016/j.ejca.2005.04.034

M3 - Article

C2 - 16098458

SN - 0959-8049

VL - 41

SP - 1751

EP - 1757

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 12

ER -